Pipeline

With our Aonys drug delivery platform and our network of experts, we are preparing numerous developments of new drugs with buccal administration and intracellular delivery of various water-soluble active ingredients.

Our goal is to provide innovative solutions in major therapeutic areas, currently lacking efficacy treatments.

Pipeline mobile EN
Product Preclinical Phase 1 Phase 2 Phase 3 Property / Partner
NEURODEGENERATIVE DISEASES
NanoLithium Alzheimer’s disease 100 100 50 0
NanoLithium Huntington’s disease 100 100 0 0
NanosiRNA Huntington’s disease 100 0 0 0
VIROLOGY
NanoManganese COVID-19 100 100 50 0
NanosiRNA COVID-19 and Influenza 100 0 0 0
ONCOLOGY
NanosiRNA IFNAR 100 0 0 0
NanoManganese
Radiotherapy Glioblastoma
100 0 0 0
NUCLEAR DRUGS
NU01 Plutonium decorporation 100 0 0 0
NU02 Cesium decorporation 100 0 0 0
NanoMn Radioprotection 100 100 0 0